Services & Solutions

Using our unique and proprietary CO₂ platform technology, FeyeCon offers you various formulation solutions for your APIs. CO₂ is GRASS, cheap and environmentally benign. In addition to addressing the challenges for your drug, using our technology will lead to reduced process costs and eliminate residual solvent issues.

INCREASED BIOAVAILABILITY
For the formulation of poorly soluble compounds a combination of CO₂ technologies can improve bioavailability significantly. The unique characteristics of our technology can lead to inventive morphology, nanostructures or encapsulations, thereby improving the bioavailability and pharmacokinetics of your product.

CONTROLLED RELEASE
Increased effort is being made by industry to develop formulations that guarantee stable drug plasma levels. For many drug products, polymer encapsulated nano- and micro-particles are being designed and developed which are capable of releasing the drug over a sustained time period. This results in a reduced frequency of administration, lower drug levels and less adverse effects. We can create polymer encapsulated APIs in a tunable and controlled manner.

ALTERNATIVE ROUTES OF ADMINISTRATION
The application of protein drugs has traditionally been limited to injection or infusion. Selection of the right polymer system can alter the hydrophilicity of protein drugs allowing them to cross the barriers of skin, gastro-intestines or mucosa. We can help you to develop alternative drug formulations for oral, sublingual, pulmonary or nasal administration.

TASTE MASKING
Bad tasting pharmaceuticals can be a big problem for your product’s success. Improving the taste of your drug over that of the competition can give you the competitive edge you need. Our technology can be used to overcome negative taste experiences for orally administered drugs.

STABILITY & SHELF LIFE
When formulation efforts prove insufficient to achieve the desired shelf life for your liquid formulation, many manufacturers develop lyophilized formulations. FeyeCon can provide an excellent alternative means to increase the shelf life of liquid formulations. Encapsulation of your API using polymers will protect the drug and reduce susceptibility to hydrolysis, oxidation or aggregation in solution. Encapsulation eliminates the need for reconstitution which can be a source of errors and contamination.

MILD DRYING
CO₂ based drying may be an excellent alternative for your product. It is fast, energy efficient and performed at mild temperature. This feature renders our technology especially suitable for drying of thermolabile compounds.

Whatever your challenges, FeyeCon has solutions!